Delivering curcumin and gemcitabine in one nanoparticle platform for colon cancer therapy
Author:
Affiliation:
1. Medical and Health Center
2. Beijing Friendship Hospital
3. Capital University of Medical Sciences
4. Beijing, China
Abstract
As gemcitabine and curcumin have different targets in colon cancer cells, combination of them may bring benefits.
Publisher
Royal Society of Chemistry (RSC)
Subject
General Chemical Engineering,General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2014/RA/C4RA10431E
Reference32 articles.
1. Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors
2. US Cancer Statistics Working Group. United States Cancer Statistics: 1999–2008 incidence and mortality web-based report, http://www.cdc.gov/uscs, accessed 30 May 2012
3. Colorectal cancer statistics, 2014
4. Gemcitabine versus Modified Gemcitabine: A Review of Several Promising Chemical Modifications
5. Phase I Trial and Pharmacokinetics of Gemcitabine in Children With Advanced Solid Tumors
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Polymeric Nanoparticles Engineered for Optimal Drug Delivery Using Atomistic Computational Simulation;ACS Applied Nano Materials;2024-08-07
2. Oral Delivery of Photopolymerizable Nanogels Loaded with Gemcitabine for Pancreatic Cancer Therapy: Formulation Design, and in vitro and in vivo Evaluations;International Journal of Nanomedicine;2024-04
3. Micelle-based curcumin delivery systems as cancer therapeutics;Curcumin-Based Nanomedicines as Cancer Therapeutics;2024
4. Comparative study of dual delivery of gemcitabine and curcumin using CD44 targeting hyaluronic acid nanoparticles for cancer therapy;Journal of Drug Delivery Science and Technology;2022-11
5. Developing photothermal-responsive and anti-oxidative silk/dopamine nanoparticles decorated with drugs which were incorporated into silk films as a depot-based drug delivery;International Journal of Biological Macromolecules;2021-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3